Results 231 to 240 of about 262,681 (286)

The efficacy and safety of sodium‐glucose cotransporter 2 inhibitors in patients aged over 80 years with heart failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Sodium‐glucose cotransporter 2 (SGLT2) inhibitors (SGLT2i) have demonstrated effectiveness in reducing cardiovascular death and heart failure hospitalization (HFH). However, the efficacy and safety of SGLT2 inhibitors in elderly patients with poor general status, such as very low bodyweight or low nutritional status, who are not included ...
Kenji Nakano   +15 more
wiley   +1 more source

Cardiopulmonary exercise testing as a prognosis‐assessing tool in heart failure with preserved ejection fraction

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Patients with heart failure with preserved ejection fraction represent half of the heart failure patients nowadays, an at least steady trend due to the aging of the population. We investigated whether the parameters obtained from cardiopulmonary exercise testing (CPET) correlated with the prognosis of these patients.
C. Rozados da Conceicao   +7 more
wiley   +1 more source

Downregulation of PGAM2 alleviates angiotensin II-induced cardiac hypertrophy by destabilizing HSP90 and inactivating the mTOR/IKKα signaling pathway. [PDF]

open access: yesInt J Biol Sci
Li Y   +13 more
europepmc   +1 more source

Glucose transporter 1 in vascular smooth muscle cells is dispensable for abdominal aortic aneurysm induced by angiotensin II. [PDF]

open access: yesJVS Vasc Sci
Torimoto K   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Angiotensin II and dengue

Archives of Virology, 2023
Dengue is a disease caused by a flavivirus that is transmitted principally by the bite of an Aedes aegypti mosquito and represents a major public-health problem. Many studies have been carried out to identify soluble factors that are involved in the pathogenesis of this infection.
Jesus A Mosquera-Sulbaran   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy